نمایش پرونده ساده آیتم

dc.contributor.advisorMohammadpoor, Ata
dc.contributor.advisorRazzagi, Alireza
dc.contributor.authorNedaei, Arezoo
dc.date.accessioned2023-11-05T08:44:36Z
dc.date.available2023-11-05T08:44:36Z
dc.date.issued2023en_US
dc.identifier.urihttps://dspace.tbzmed.ac.ir:443/xmlui/handle/123456789/69713
dc.description.abstractBell's palsy is a rare side effect reported in COVID-19 vaccines. Given the importance of neurological manifestations, the necessity to highlight and analyze the incidence of them after COVID-19 vaccination is needed. This study aimed to systematically review the reported cases of Bell's palsy following vaccination against COVID-19. Search method: This systematic review is implemented based on the Cochrane Collaboration Handbook and PRISMA Statement (Preferred Reporting Items for Systematic Reviews and Meta-Analyzes), and the proposed systematic review was conducted following the Joanna Briggs Institute (JBI) methodology for systematic reviews. The inclusion criteria for the included published studies were patient age ≥18 years; history of Bell's palsy post-COVID-19 vaccination and proved diagnosis in the patients with COVID-19 vaccination. The exclusion criteria for the studies were duplicate studies that included repetition of cases and studies with missing clinical data . The search strategy aimed to find both published and unpublished studies in August 2021 and updated by hand searching using the identified keywords and index terms in Cochrane Library, MEDLINE (PubMed), Web of Science, Scopus, ProQuest, and Google scholar in May 2022 . Finally, the reference lists of all identified reports and articles were searched for more studies. The JBI critical appraisal tools for case reports or case series were used to determinate the risk of bias in the included studies. Results: During the electronic search, manual search, and reference check, we found 1281 citations, and in hand searching, we detected additional 15 studies. After discarding duplicated citations, and evaluating the title, abstract, and full text 15 case-report and two case-series studies were included for the critical appraisal process and were included in this study. Pfizer and Moderna vaccines were the most common vaccines among studies that revealed the cases of Bell’s palsy. Paralysis of left side was more common than right-sided paralysis. The interval between vaccination and the manifestations of Bell's palsy (facial weakness) was between 1 and 48 days.en_US
dc.language.isofaen_US
dc.publisherTabriz University of Medical Sciences, Faculty of Medicineen_US
dc.relation.isversionofhttps://dspace.tbzmed.ac.ir:443/xmlui/handle/123456789/69712en_US
dc.subjectBell's palsyen_US
dc.subjectCOVID-19 vaccinationen_US
dc.subjectSystematic reviewen_US
dc.titleBell's palsy and COVID-19 vaccination: a systematic reviewen_US
dc.typeThesisen_US
dc.contributor.supervisorShahsavarinia, Kavous
dc.contributor.supervisorSalehipourmehr, Hanieh
dc.identifier.docno6011300en_US
dc.identifier.callno11300en_US
dc.description.disciplineMedicineen_US
dc.description.degreeMD Degreeen_US


فایلهای درون آیتم

فایلهاسایزفرمتنمایش

هیچ فایل مرتبطی وجود ندارد

این آیتم در مجموعه های زیر مشاهده می شود

نمایش پرونده ساده آیتم